Laurie W. Cuttino, MD

Articles by Laurie W. Cuttino, MD

Limited-Field and Whole-Breast Hypofractionated Radiotherapy

ByJ. Ben Wilkinson, MD,Laurie W. Cuttino, MD,Thomas B. Julian, MD,Douglas W. Arthur, MD,Frank A. Vicini, MD

September 13th 2012

With the publication of mature experiences using accelarated partial breast irradiation (APBI) and accelerated whole breast irradiation (AWBI), the use of shortened courses of radiotherapy has become increasingly popular.

Latest Updated Articles

$Limited-Field and Whole-Breast Hypofractionated Radiotherapy$
Limited-Field and Whole-Breast Hypofractionated Radiotherapy
September 13th 2012

Trending on CancerNetwork

FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy

Daraxonrasib Shows Anti-Tumor Activity in Pretreated RAS+ Pancreatic Cancer

FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer

TIP125 ReDiscover-2, a Phase 3 Study of Zovegalisib (RLY-2608) + Fulvestrant Versus Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-Mutant HR+/ HER2- Breast Cancer Following Recurrence or Progression on or After Treatment With a CDK4/6 Inhibitor (Trial in Progress)